Discover A Treatment Experience With
The only ultra-low-dose vaginal estradiol available in both 4-mcg and 10-mcg doses1,2
Proven efficacy with early onset of action at 2 weeks1,3*
Applicator-free and mess-free administration1,3
*Secondary endpoint from a 12-week clinical trial.3
IMVEXXY is a vaginal estrogen treatment option for moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. Vulvar and vaginal atrophy may also be known as vulvovaginal atrophy, atrophic vaginitis, or vaginal atrophy.4
IMVEXXY is a bio-identical,* softgel vaginal insert that offers an applicator-free experience with mess-free administration, no dose preparation, and any time of day dosing, which may help support patient compliance. IMVEXXY is the only ultra-low-dose vaginal estradiol available in both 4-mcg and 10-mcg doses.1,2,5,6
*The relevance of risks associated with the use of synthetic hormones compared to bio-identical hormones is not known but cannot be excluded.
Program Terms, Conditions, and Eligibility Criteria
For questions about this program please call 347-442-7919.
For healthcare professionals